AI-Rad Companion Prostate MR

AI-Rad Companion Prostate MR is a software tool intended to assist clinicians in the analysis of MR prostate images to support MR-US fusion biopsy procedures through enhanced image viewing, manipulation, and evaluation. It leverages cloud-based artificial intelligence for automatic prostate segmentation, volume estimation, lesion annotation, and PSA density calculation, aiming to streamline and improve the accuracy of prostate biopsy planning and reporting.

AI-Rad Companion Prostate MR is a post-processing image analysis software designed to assist clinicians in viewing, manipulating, analyzing, and evaluating MR prostate images, primarily for supporting US-guided MR-US fusion biopsies. The software addresses the challenge of accurately communicating lesion locations and prostate volume between radiologists and urologists, aiming to improve the precision of targeted biopsies by providing tools to communicate the location and spatial extent of lesions and the prostate volume from MR images. The system is a cloud-based software that utilizes artificial intelligence algorithms to process prostate MR DICOM images. Its core functionalities include automatic segmentation and quantitative analysis of the prostate gland, including volume estimation, with options for manual adjustments. The software also allows for manual annotation of relevant findings (lesions), calculates PSA density based on user-inputted PSA values, and exports results in formats suitable for PACS archiving and for import by ultrasound systems (e.g., RTStruct) to facilitate MR-US fusion biopsy procedures.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What is the quantified accuracy and variability of the automatic prostate segmentation and volume estimation compared to manual segmentation by expert radiologists across diverse patient cohorts?; How does the integration of AI-Rad Companion Prostate MR into the clinical workflow impact the overall time taken for biopsy preparation and the efficiency of MR-US fusion procedures?; What types of artificial intelligence algorithms are utilized for the segmentation and quantitative analysis, and what were the key performance metrics achieved during their development and validation?; How does the software handle challenging cases, such as prostates with significant anatomical variations, post-treatment changes, or images with artifacts, in its automatic segmentation and analysis?; What are the specific data security and privacy measures implemented within the cloud-based architecture to protect sensitive patient MR DICOM data during processing and transfer?